Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients

Clinical Science

Volumn 116, Issue 11-12, 2009, Pages 861-870

  Körner, Christian ^a   Krämer, Benjamin ^a   Schulte, Daniela ^a   Coenen, Martin ^a   Mauss, Stefan ^b   Fätkenheuer, Gerd ^c   Oldenburg, Johannes ^a   Nattermann, Jacob ^a   Rockstroh, Jürgen K ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Center for HIV and Hepatogastroenterology   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RITONAVIR; SAQUINAVIR; TENOFOVIR; ZIDOVUDINE; FROSAMPRENAVIR; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ASSAY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EX VIVO STUDY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NICK END LABELING; PRIORITY JOURNAL; VIRUS LOAD; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 67649295524     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080532     Document Type: Article

References (42)

1. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. and Earnshaw, W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347 (Pubitemid 24300618)
2. + T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84, 1649-1661
3. Miura, Y. and Koyanagi, Y. (2005) Death ligand-mediated apoptosis in HIV infection. Rev. Med. Virol. 15, 169-178
4. Varbanov, M., Espert, L. and Biard-Piechaczyk, M. (2006) Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins. AIDS Rev. 8, 221-236 (Pubitemid 46138920)
5. Taya, N., Torimoto, Y., Shindo, M., Hirai, K., Hasebe, C. and Kohgo, Y. (2000) Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br. J. Haematol. 110, 89-97
6. Fischer, R., Baumert, T. and Blum, H. E. (2007) Hepatitis C virus infection and apoptosis. World J. Gastroenterol. 13, 4865-4872
7. Rockstroh, J. K. and Spengler, U. (2004) HIV and hepatitis C virus co-infection. Lancet Infect. Dis. 4, 437-444
8. Anderson, K. B., Guest, J. L. and Rimland, D. (2004) Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin. Infect. Dis. 39, 1507-1513
9. Greub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Burgisser, P., Erb, P., Boggian, K., Piffaretti, J. C. et al. (2000) Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356, 1800-1805 (Pubitemid 30954033)
10. Giordano, T. P., Kramer, J. R., Souchek, J., Richardson, P. and El-Serag, H. B. (2004) Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch. Intern. Med. 164, 2349-2354
11. Pineda, J. A., Romero-Gomez, M., Diaz-Garcia, F., Giron-Gonzalez, J. A., Montero, J. L., Torre-Cisneros, J., Andrade, R. J., Gonzalez-Serrano, M., Aguilar, J., Aguilar-Guisado, M. et al. (2005) HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41, 779-789 (Pubitemid 40462940)
12. Kramer, J. R., Giordano, T. P., Souchek, J. and El-Serag, H. B. (2005) Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J. Hepatol. 42, 309-314 (Pubitemid 40254243)
13. El-Serag, H. B., Giordano, T. P., Kramer, J., Richardson, P. and Souchek, J. (2005) Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin. Gastroenterol. Hepatol. 3, 175-183
14. Rockstroh, J. K., Mocroft, A., Soriano, V., Tural, C., Losso, M. H., Horban, A., Kirk, O., Phillips, A., Ledergerber, B. and Lundgren, J. (2005) Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J. Infect. Dis. 192, 992-1002
15. Roger, P. M., Breittmayer, J. P., Arlotto, C., Pugliese, P., Pradier, C., Bernard-Pomier, G., Dellamonica, P. and Bernard, A. (1999) Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin. Exp. Immunol. 118, 412-416
16. Qurishi, N., Kreuzberg, C., Luchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K. and Spengler, U. (2003) Effect of antiretroviral therapy on liver-related mortality in patients with HIV and nepatitis C virus coinfection. Lancet 362, 1708-1713 (Pubitemid 37468321)
17. Brau, N., Salvatore, M., Rios-Bedoya, C. F., Fernandez-Carbia, A., Paronetto, F., Rodriguez-Orengo, J. F. and Rodriguez-Torres, M. (2006) Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J. Hepatol. 44, 47-55 (Pubitemid 41772515)
18. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (Pubitemid 28079208)
19. Sakahira, H., Enari, M. and Nagata, S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99 (Pubitemid 28079223)
20. Walker, P. R., Kokileva, L., LeBlanc, J. and Sikorska, M. (1993) Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques 15, 1032-1040 (Pubitemid 24002554)
21. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T. and Traganos, F. (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27, 1-20 (Pubitemid 27059777)
22. Nunez, M., Soriano, V., Lopez, M., Ballesteros, C., Cascajero, A., Gonzalez-Lahoz, J. and Benito, J. M. (2006) Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients. Clin. Infect. Dis. 43, 1209-1212
23. Munshi, N., Balasubramanian, A., Koziel, M., Ganju, R. K. and Groopman, J. E. (2003) Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J. Infect. Dis. 188, 1192-1204
24. Iio, S., Hayashi, N., Mita, E., Ueda, K., Mochizuki, K., Hiramatsu, N., Kanto, T., Sasaki, Y., Kasahara, A. and Hori, M. (1998) Serum levels of soluble Fas antigen in chronic hepatitis C patients. J. Hepatol. 29, 517-523 (Pubitemid 28484939)
25. Zylberberg, H., Rimaniol, A. C., Pol, S., Masson, A., De Groote, D., Berthelot, P., Bach, J. F., Brechot, C. and Zavala, F. (1999) Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30, 185-191 (Pubitemid 29071178)
26. Zhang, M., Li, X., Pang, X., Ding, L., Wood, O., Clouse, K., Hewlett, I. and Dayton, A. I. (2001) Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J. Biomed. Sci. 8, 290-296
27. Bahr, G. M., Capron, A., Dewulf, J., Nagata, S., Tanaka, M., Bourez, J. M. and Mouton, Y. (1997) Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection. Blood 90, 896-898 (Pubitemid 27299137)
28. Fadeel, B., Samuelsson, A., Hachiya, T., Brostrom, C. and Chiodi, F. (1996) Elevated serum levels of soluble Fas/APO-1 in human immunodeficiency virus-infected individuals. Blood 88, 4727-4730 (Pubitemid 26419160)
29. Badley, A. D., Dockrell, D. H., Algeciras, A., Ziesmer, S., Landay, A., Lederman, M. M., Connick, E., Kessler, H., Kuritzkes, D., Lynch, D. H. et al. (1998) In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102, 79-87
30. Katsikis, P. D., Wunderlich, E. S., Smith, C. A. and Herzenberg, L. A. (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036
31. Herbeuval, J. P., Boasso, A., Grivel, J. C., Hardy, A. W., Anderson, S. A., Dolan, M. J., Chougnet, C., Lifson, J. D. and Shearer, G. M. (2005) TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105, 2458-2464
32. + cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J. Virol. 77, 6700-6708 (Pubitemid 36666864)
33. Chou, A. H., Tsai, H. F., Wu, Y. Y., Hu, C. Y., Hwang, L. H., Hsu, P. I. and Hsu, P. N. (2005) Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174, 2160-2166 (Pubitemid 40223960)
34. Dewan, M. Z., Uchihara, J. N., Terashima, K., Honda, M., Sata, T., Ito, M., Fujii, N., Uozumi, K., Tsukasaki, K., Tomonaga, M. et al. (2006) Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. Blood 107, 716-724 (Pubitemid 43076398)
35. Gaedicke, S., Firat-Geier, E., Constantiniu, O., Lucchiari-Hartz, M., Freudenberg, M., Galanos, C. and Niedermann, G. (2002) Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis. Cancer Res. 62, 6901-6908 (Pubitemid 35424079)
36. Andre, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth, Jr, B. L., Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M. and Lotteau, V. (1998) An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. U.S.A. 95, 13120-13124
37. Ikezoe, T., Saito, T., Bandobashi, K., Yang, Y., Koeffler, H. P. and Taguchi, H. (2004) HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2. Mol. Cancer Ther. 3, 473-479
38. De Luca, A., Bugarini, R., Lepri, A. C., Puoti, M., Girardi, E., Antinori, A., Poggio, A., Pagano, G., Tositti, G., Cadeo, G. et al. (2002) Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch. Intern. Med. 162, 2125-2132
39. Braitstein, P., Zala, C., Yip, B., Brinkhof, M. W., Moore, D., Hogg, R. S. and Montaner, J. S. (2006) Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program. J. Infect. Dis. 193, 259-268
40. Yacisin, K., Maida, I., Rios, M. J., Soriano, V. and Nunez, M. (2008) Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy. AIDS Res. Hum. Retroviruses 24, 935-940
41. Sulkowski, M. S., Moore, R. D., Mehta, S. H., Chaisson, R. E. and Thomas, D. L. (2002) Hepatitis C and progression of HIV disease. JAMA, J. Am. Med. Assoc. 288, 199-206 (Pubitemid 34755280)
42. Shafran, S. D. (2007) Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients. J. Acquired Immune Defic. Syndr. 44, 551-556